Hosted on MSN1d
FDA Updates EXEL on Previously Scheduled ODAC Meeting for Cabozantinib
Exelixis, Inc. EXEL announced that the FDA has notified it about an update to its supplemental new drug application (sNDA) ...
Woman from Myanmar undergoes liver transplant at hospital in Chennai
A 66-year-old woman from Myanmar underwent a liver transplant surgery at a private hospital in the city.
Too Old to Operate1d
Advancements in Lenvatinib and ICIs for Liver Cancer
The following is a summary of “Lenvatinib and immune-checkpoint inhibitors in hepatocellular carcinoma: mechanistic insights, ...
Q&A: Researchers discuss lipid nanoparticle therapy to stop tumor growth and restore tumor suppression
Yang Zhang, Ph.D., and Jinjun Shi, Ph.D., both of the Center for Nanomedicine and Department of Anesthesiology, Perioperative ...
Armed robbery in Revesby1d
Liver Cancer Treatment Breakthrough in Global Study
Researchers at Mount Sinai have made a breakthrough in treating a type of liver cancer called hepatocellular carcinoma (HCC).
News Medical1d
RNA nanoparticles offer dual action against prostate tumors
Yang Zhang, PhD, and Jinjun Shi, PhD, both of the Center for Nanomedicine and Department of Anesthesiology, Perioperative and ...
The Guam Daily Post1d
GRMC welcomes one of 2 gastroenterologists with specialty in liver care
Guam Regional Medical City is excited to announce the addition of Dr. Supannee "Jill' Rassameehiran, a board-certified ...
Armed robbery in Revesby1d
Lipid Nanoparticle Therapy Halts Tumor Growth
Yang Zhang, PhD, and Jinjun Shi, PhD, both of the Center for Nanomedicine and Department of Anesthesiology, Perioperative and Pain Medicine at Brigham ...
Combination treatment for liver cancer significantly improves progression-free survival in global trial
Researchers at Mount Sinai have made a breakthrough in treating a type of liver cancer called hepatocellular carcinoma (HCC).
MedPage Today2d
Best Diets for GI Conditions; Twin Pregnancies With IBD; Mortality Risk in MAFLD
U.S. News released its list of best diets for 2025: the low-FODMAP diet landed on top for irritable bowel syndrome and the ...
Exelixis says no FDA AdCom for Cabometyx label expansion
Exelixis (NASDAQ:EXEL) announced Thursday that the U.S. Food and Drug Administration (FDA) no longer plans to conduct an ...
El País in English2d
Three-pronged treatment improves prognosis for inoperable liver cancer
Two independent studies reveal that disease progression is delayed by combining two targeted therapies with the traditional ...